| Literature DB >> 31155751 |
Barry J Ruijter1, Marleen C Tjepkema-Cloostermans2, Selma C Tromp3, Walter M van den Bergh4, Norbert A Foudraine5, Francois H M Kornips6, Gea Drost7, Erik Scholten8, Frank H Bosch9, Albertus Beishuizen10, Michel J A M van Putten1,2, Jeannette Hofmeijer1,11.
Abstract
OBJECTIVE: To provide evidence that early electroencephalography (EEG) allows for reliable prediction of poor or good outcome after cardiac arrest.Entities:
Year: 2019 PMID: 31155751 PMCID: PMC6771891 DOI: 10.1002/ana.25518
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422
Figure 1Examples of synchronous patterns with ≥50% suppression. (A) Burst suppression with identical bursts. (B) Burst suppression with abrupt‐onset, generalized bursts (these bursts could alternatively be described as “highly epileptiform bursts”). (C) Burst suppression with abrupt‐onset, generalized bursts, alternating with generalized discharges. (D) Generalized periodic discharges on a suppressed background. [Color figure can be viewed at www.annalsofneurology.org]
Patient Characteristics, Grouped by Outcome
| Characteristic | Poor Outcome, CPC = 3–5 | Good Outcome, CPC = 1–2 |
|
|---|---|---|---|
| n | 455 (54%) | 395 (46%) | |
| Age, yr | 67 (57–75) | 60 (51–69) | <0.001 |
| Female | 121 (27%) | 84 (21%) | 0.07 |
| Out‐of‐hospital cardiac arrest | 407 (89%) | 367 (93%) | 0.08 |
| Noncardiac cause of arrest | 94 (24%) | 21 (6%) | <0.001 |
| Ventricular fibrillation as initial cardiac rhythm | 248 (58%) | 352 (91%) | <0.001 |
| Mild therapeutic hypothermia, 33°C | 214 (47%) | 179 (45%) | 0.62 |
| EEG start time, hours after cardiac arrest | 11 (6–19) | 11 (6–19) | 0.70 |
| EEG stop time, hours after cardiac arrest | 62 (42–93) | 52 (41–78) | 0.01 |
| Treatment with propofol | 379 (85%) | 354 (91%) | 0.01 |
| Max dose in first 24 hours, mg/kg/h | 2.7 (2.0–3.5) | 3.2 (2.4–3.9) | <0.001 |
| Cumulative dose at 24 hours, mg/kg | 52 (39–64) | 63 (49–77) | <0.001 |
| Treatment with midazolam | 124 (28%) | 111 (29%) | 0.80 |
| Max dose in first 24 hours, μg/kg/h | 100 (57–170) | 93 (66–153) | 0.85 |
| Cumulative dose at 24 hours, mg/kg | 0.65 (0.41–1.03) | 1.10 (0.51–1.51) | 0.04 |
| Treatment with fentanyl | 201 (45%) | 160 (41%) | 0.26 |
| Max dose in first 24 hours, μg/kg/h | 1.3 (1.0–1.8) | 1.4 (1.1–2.3) | 0.03 |
| Cumulative dose at 24 hours, μg/kg | 27 (22–38) | 32 (25–48) | 0.001 |
| Treatment with remifentanil | 33 (7%) | 21 (5%) | 0.24 |
| Max dose in first 24 hours, μg/kg/h | 3.6 (2.5–5.6) | 6.6 (3.3–11.4) | 0.02 |
| Cumulative dose at 24 hours, μg/kg | 56 (27–102) | 84 (57–166) | 0.04 |
| Treatment with morphine | 174 (39%) | 193 (50%) | <0.001 |
| Max dose in first 24 hours, μg/kg/h | 25 (22–31) | 25 (21–29) | 0.17 |
| Cumulative dose at 24 hours, μg/kg | 429 (247–514) | 453 (374–527) | 0.20 |
| Treatment with sevoflurane | 30 (7%) | 21 (5%) | 0.43 |
| Max end–tidal volume % | 1.2 (1.1–1.4) | 1.4 (1.2–1.6) | 0.03 |
| SSEP performed | 276 (61%) | 43 (11%) | <0.001 |
| N20 bilaterally absent | 123 (27%) | 0 (0%) | <0.001 |
Data are shown as number (percentage) or median (interquartile range).
CPC = Cerebral Performance Category; EEG = electroencephalogram; Max = maximum; SSEP = somatosensory evoked potential.
Figure 2Chance of good outcome, given the electroencephalographic (EEG) pattern and its timing after cardiac arrest. In each cell, the percentage indicates the chance of good outcome, the numbers in parentheses the corresponding 95% confidence interval, and N the number of patients with the EEG pattern at the given time. BS = burst suppression; GPD = generalized periodic discharge; Supp. = suppression; supp. bg. = suppressed background pattern. [Color figure can be viewed at www.annalsofneurology.org]
Figure 3Predictive value of the electroencephalogram (EEG) as a function of time after cardiac arrest. "Corrected" values follow from the mixed model, which accounts for the sensitivity and specificity at the 8 time points being calculated from different, partially overlapping groups of patients. Error bars indicate 95% confidence intervals. Numbers (N) refer to the total number of patients with an EEG epoch available at the indicated time point. (A) Test characteristics for the prediction of poor outcome based on “suppression” or “synchronous pattern with ≥50% suppression.” (B) Test characteristics for the prediction of good outcome based on "continuous" EEG pattern. [Color figure can be viewed at www.annalsofneurology.org]
Comparison of Treatment and Predictive Values of Electroencephalography between Centers
| Center 1 | Center 2 | Center 3 | Center 4 | Center 5 | All | |
|---|---|---|---|---|---|---|
| Recruitment period | May 2010–Nov 2017 | Jun 2012–Oct 2017 | Jul 2015–Oct 2017 | Oct 2014–Aug 2017 | Feb 2016–Nov 2017 | May 2010–Nov 2017 |
| Subjects, n | 351 | 272 | 93 | 67 | 67 | 850 |
| Medication, ≤24h after CA | ||||||
| Propofol | 343 (98%) | 222 (86%) | 92 (99%) | 66 (99%) | 7 (10%) | 730 (86%) |
| Midazolam | 70 (20%) | 136 (53%) | 2 (2%) | 13 (19%) | 16 (24%) | 237 (28%) |
| Sevoflurane | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 51 (76%) | 51 (6%) |
| Morphine | 3 (1%) | 248 (96%) | 76 (82%) | 39 (58%) | 0 (0%) | 366 (43%) |
| Fentanyl | 294 (84%) | 0 (0%) | 0 (0%) | 2 (3%) | 63 (94%) | 359 (42%) |
| Remifentanil | 45 (13%) | 1 (0%) | 8 (9%) | 0 (0%) | 0 (0%) | 54 (6%) |
| Hypothermia, 33°C | 311 (89%) | 75 (28%) | 0 (0%) | 0 (0%) | 7 (10%) | 393 (46%) |
| Prediction of poor outcome, 12 hours after CA | ||||||
| Sensitivity (95% CI) | 0.55 (0.48–0.61) | 0.42 (0.34–0.51) | 0.43 (0.28–0.59) | 0.13 (0.01–0.42) | 0.36 (0.22–0.51) | 0.47 (0.42–0.51) |
| Specificity (95% CI) | 1.00 (0.98–1.00) | 1.00 (0.96–1.00) | 1.00 (0.89–1.00) | 1.00 (0.70–1.00) | 1.00 (0.90–1.00) | 1.00 (0.99–1.00) |
| Prediction of good outcome, 12 hours after CA | ||||||
| Sensitivity (95% CI) | 0.46 (0.39–0.52) | 0.46 (0.37–0.54) | 0.56 (0.39–0.71) | 0.75 (0.43–0.95) | 0.88 (0.74–0.96) | 0.50 (0.46–0.55) |
| Specificity (95% CI) | 0.94 (0.90–0.97) | 0.84 (0.77–0.90) | 0.95 (0.82–1.00) | 0.88 (0.55–1.00) | 0.89 (0.76–0.97) | 0.91 (0.88–0.93) |
Values are shown per center and for the overall cohort (All). Prediction of poor outcome was based on the presence of an unfavorable pattern (generalized suppression or synchronous pattern with ≥50% suppression). Prediction of good outcome was based on the presence of a continuous pattern.
CA = cardiac arrest; CI = confidence interval.
Figure 4Prognostic yield of repeated electroencephalographic (EEG) assessment. This analysis includes only patients with an EEG recording started within 6 hours after cardiac arrest. Bars indicate the fraction of subjects in whom an unfavorable (“suppression” or “synchronous pattern with ≥50% suppression”) or favorable EEG pattern ("continuous") was observed up to the indicated time point, respectively. (A) Results for all 185 patients with poor outcome. (B) Results for all 155 patients with good outcome. [Color figure can be viewed at www.annalsofneurology.org]
Multivariate Models
| Full Model | Reduced Model | |||
|---|---|---|---|---|
| B (SE) |
| B (SE) |
| |
| Prediction of poor outcome | ||||
| Intercept | −1.032 (0.839) | 0.21 | −1.051 (0.716) | 0.14 |
| Age | 0.039 (0.010) | <0.001 | 0.040 (0.010) | <0.001 |
| Female | 0.000 (0.300) | 1.00 | ||
| Out‐of‐hospital cardiac arrest | −0.159 (0.410) | 0.69 | ||
| Noncardiac cause of arrest | 0.311 (0.436) | 0.47 | ||
| VF as initial cardiac rhythm | −1.432 (0.363) | <0.001 | −1.547 (0.312) | <0.001 |
| Mild therapeutic hypothermia, 33°C | −0.389 (0.298) | 0.19 | −0.509 (0.266) | 0.06 |
| Propofol dose, mg/kg/h | −0.181 (0.094) | 0.05 | −0.178 (0.083) | 0.03 |
| Midazolam dose, μg/kg/h | −0.001 (0.003) | 0.79 | ||
| Fentanyl dose, μg/kg/h | −0.084 (0.186) | 0.65 | ||
| Remifentanil dose, μg/kg/h | 0.005 (0.080) | 0.95 | ||
| Morphine dose, μg/kg/h | 0.008 (0.012) | 0.51 | ||
| Unfavorable EEG at 12 hours | 5.922 (1.400) | <0.001 | 5.957 (1.428) | <0.001 |
| Favorable EEG at 12 hours | N.A. | N.A. | N.A. | N.A. |
| Prediction of good outcome | ||||
| Intercept | −1.644 (0.862) | 0.06 | −1.602 (0.680) | 0.02 |
| Age | −0.028 (0.009) | 0.003 | −0.027 (0.009) | 0.002 |
| Female | 0.177 (0.287) | 0.54 | ||
| Out‐of‐hospital cardiac arrest | 0.111 (0.435) | 0.80 | ||
| Noncardiac cause of arrest | −0.560 (0.404) | 0.17 | ||
| VF as initial cardiac rhythm | 1.871 (0.358) | <0.001 | 2.130 (0.312) | <0.001 |
| Mild therapeutic hypothermia, 33°C | 0.216 (0.285) | 0.45 | ||
| Propofol dose, mg/kg/h | 0.333 (0.089) | <0.001 | 0.311 (0.083) | <0.001 |
| Midazolam dose, μg/kg/h | 0.001 (0.002) | 0.56 | ||
| Fentanyl dose, μg/kg/h | 0.194 (0.171) | 0.26 | 0.221 (0.128) | 0.09 |
| Remifentanil dose, μg/kg/h | 0.003 (0.084) | 0.97 | ||
| Morphine dose, μg/kg/h | −0.002 (0.011) | 0.85 | ||
| Unfavorable EEG at 12 hours | N.A. | N.A. | N.A. | N.A. |
| Favorable EEG at 12 hours | 2.531 (0.314) | <0.001 | 2.484 (0.304) | <0.001 |
Multivariate models for prediction of outcome. Doses of anesthetic drugs refer to the maximum doses within the first 24 hours after cardiac arrest.
For the prediction of poor outcome, the difference in AUC of the ROC curve between the full model (0.87, 95% CI = 0.83–0.90) and the reduced model (0.87, 95% CI = 0.83–0.90) was not statistically significant.
For the prediction of good outcome, the difference in AUC of the ROC curve between the full model (0.85, 95% CI = 0.81–0.88) and the reduced model (0.84, 95% CI = 0.81–0.88) was not statistically significant. ROC curves indicating the performance of the reduced models are shown in Figure 5.
AUC = area under the curve; B = model coefficient; CI = confidence interval; EEG = electroencephalogram; N.A. = not applicable; ROC = receiver operating characteristic; SE = standard error; VF = ventricular fibrillation.
Figure 5Receiver operating characteristic (ROC) curves for multivariate models. Solid lines indicate ROC curves, lighter areas the corresponding 95% confidence intervals. Each subfigure shows results for the model without electroencephalography (EEG) and the model including EEG. Details for models that include EEG are shown in Table 3. (A) Models for prediction of poor outcome. Clinical parameters include age, initial cardiac rhythm (ventricular fibrillation [VF] or other), maximum dose of propofol in the first 24 hours after cardiac arrest, and the application of hypothermia (yes or no). (B) Models for prediction of good outcome. Clinical parameters include age, initial cardiac rhythm (VF or other), and maximum doses of propofol and fentanyl in the first 24 hours after cardiac arrest. [Color figure can be viewed at www.annalsofneurology.org]